ArticleMemorias do Instituto Oswaldo Cruz2026
Immunoinformatic analysis for identifying immunogenic antigens from the complete proteome of Giardia lamblia.
Article in Memorias do Instituto Oswaldo Cruz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiardia lamblia is a parasite that infects humans. To date, there is no vaccine available for human giardiasis. Thus, discovering new immunogenic antigens is crucial for the rational design of a vaccine.
objectivesThis study aimed to identify the main immunogenic antigens of G. lamblia from its entire proteome using immunoinformatic and data science techniques. To our knowledge, this is the first study to systematically identify immunogenic antigens of G. lamblia across its complete proteome, providing a comprehensive map of potential immunogenic antigens.
methodsBriefly, FASTA sequences of G. lamblia isolates WB and GS were submitted to the NetMHCII 2.3 predictor. The analysis was conducted for five murine major histocompatibility complex (MHC)-II molecules: I-Ab, I-Ad, I-Ed, I-Ak, and I-Ek. Python 3.9 was used to develop custom code for data processing and analysis.
findingsWe identified 414 potential immunogenic polypeptides for isolate WB and 350 for isolate GS. For both isolates, most polypeptides contained peptides with high affinity for I-Ab and I-Ek. Notably, no polypeptides with high affinity for I-Ak were detected. Homologous potential immunogenic antigens (129 polypeptides) were identified in both isolates. The analysis revealed that 12 potential immunogenic polypeptides from isolate WB and 10 from isolate GS are part of the Giardia secretome. Additionally, promiscuous polypeptides that bind to at least two different MHC-II molecules were found in both isolates. MAIN
conclusionsThese findings lay a valuable foundation for the rational development of a vaccine against human giardiasis and show a computational strategy that can be applied to the study of other pathogens.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.